Date Invested

Initial Round

June 2019

Total Invested: £1,000,000

three dots - visual break

The power behind the cure

uMed is a technology platform embedded within a global network of healthcare providers that automates the process of building high quality prospective research registries.

While others rely on aggregated data which blocks subject re-engagement, uMed can rapidly reach back to contact patients for clinical studies, engage in data collection from home, and collect biomarker and genomics samples.

Visit uMedSummary of Initial RoundSummary of Second Round


Matt Wilson CEO
Three Dots Small
Linked In

Why we Invested?

uMed provides the missing piece to unlock the huge value in healthcare data — scalable, repeatable, compliant patient engagement.

Their solution is a win-win-win: patients get access to the latest clinical research, trials and therapies to improve health outcomes; healthcare providers are empowered to offer a better service to their patients with minimum time investment; and pharma/researchers can identify and engage with patient cohorts (pre, post or as part of a trial) in a matter of clicks and leverage electronic health records to deliver rapid, cost efficient studies across large patient populations.

'Why we invested' Blog